The most direct route to FDA device labeling documents depends on whether you need the regulatory requirements, a manufacturer-submitted label, or guidance interpreting those requirements. The FDA Online Label Repository at labels.fda.gov holds device labeling that manufacturers have voluntarily submitted, while the eCFR contains the binding labeling rules in 21 CFR Part 801. FDA guidance documents describe agency policy without creating legal obligations. Because these sources serve different purposes, a reliable search starts by naming the document type you need and then checking the verification status of whatever record you retrieve. The repository itself states that device labeling has not been reviewed by FDA before posting and may not match the labeling on currently distributed products [1]. That distinction shapes every downstream decision in a labeling research workflow.
Start with the FDA Online Label Repository
The FDA Online Label Repository is the primary public entry point for searching device labeling documents. The site links to a search interface and notes that device-specific information has been voluntarily submitted by manufacturers [1]. FDA has not reviewed this information prior to posting, and the device labeling has been reformatted for readability without content alteration or verification [1]. This means the repository is useful for locating a manufacturer's submitted label text, but it cannot confirm that the text reflects an approved or currently marketed version.
The repository also points researchers to DailyMed, the National Library of Medicine site where labels can be searched by drug name and linked to library information resources [1]. For bulk work, health information suppliers can download all electronic files companies have submitted through the National Library of Medicine's Download Labels site [1]. Questions about structured product labeling data can be sent to the SPL Coordinator at spl@fda.hhs.gov [1]. These routes are appropriate when the goal is retrieving submitted label content rather than establishing regulatory status.
Separate Labeling Rules from Submitted Labels
The binding device labeling requirements appear in 21 CFR Part 801, which the eCFR displays as authoritative but unofficial content [3]. The official published CFR is updated annually and available through govinfo.gov, while the eCFR may include more recent changes [3]. Researchers who need the current enforceable text should compare the eCFR version against the official annual publication when a recent amendment could affect the provision they are citing.
FDA's Device Labeling page clarifies the legal scope of the term. Section 201(m) defines labeling as all labels and other written, printed, or graphic matter upon an article or its containers, or accompanying the article at any time while held for sale after shipment in interstate commerce [2]. The agency interprets accompanying liberally to include posters, tags, pamphlets, circulars, booklets, brochures, instruction books, direction sheets, and fillers [2]. An appellate court decision quoted by FDA states that most, if not all, advertising is labeling [2]. This broad definition means a labeling search may need to include promotional and instructional materials, not only the physical label.
Reading a Device Label Record Without Overclaiming
When you open a device label from the repository, note the disclaimer language before using the content. The site states that device labeling has been voluntarily submitted, has not been reviewed by FDA prior to posting, and may not be the labeling on currently distributed products [1]. Record the retrieval date and the source URL so a later version change can be detected. If the device is subject to a specific labeling rule, such as the hearing aid software labeling provisions in 21 CFR Part 801, compare the submitted text against the eCFR requirement rather than assuming compliance [3]. For questions about structured product labeling files, the SPL Coordinator contact is spl@fda.hhs.gov [1].
Use Guidance Documents for Agency Interpretation
FDA guidance documents describe the agency's interpretation of or policy on a regulatory issue for staff, industry, and the public [5]. They cover design, production, labeling, promotion, manufacturing, testing, submission processing, and inspection policy [5]. Guidance documents do not establish rights for any person and are not binding on FDA or the public; an alternative approach may be used if it satisfies the applicable statute and regulations [5]. This nonbinding status matters when a labeling question turns on an interpretive point rather than a direct CFR requirement.
The guidance database includes a searchable filter set with topics such as Labeling, UDI, GUDID, Premarket, and IVDs, along with filters for draft or final status and comment closing dates [5]. The Device Labeling page lists specific labeling guidance documents, including Labeling - Regulatory Requirements for Medical Devices, Device Labeling Guidance #G91-1, and Guidance on Medical Device Patient Labeling [2]. These documents can clarify how FDA expects manufacturers to apply Part 801 in particular device categories, but they should be cited as policy statements rather than legal requirements.
Check What a Retrieved Label Actually Verifies
A retrieved device label carries a specific evidentiary status. The FDA Online Label Repository states that device labeling has been voluntarily submitted and not reviewed by FDA prior to posting [1]. The content has been reformatted but not altered or verified, and it may not be the labeling on currently distributed products [1]. For drug labeling, the FDALabel database similarly warns that SPL documents may not be identical to the most recent FDA-approved labeling at Drugs@FDA and that SPL contents have not been verified by FDA [6]. Researchers should not treat a repository hit as proof of approval, clearance, or current market status.
Registration and listing create a related confusion. FDA's device marketing page states that registration of a device establishment, assignment of a registration number, or listing of a medical device does not in any way denote clearance or approval of the establishment or its products by FDA [4]. A device may appear in listing data while its labeling remains unverified. When a labeling document is needed for a regulatory submission or compliance review, the safest practice is to retrieve the CFR text for the requirement, the guidance for interpretation, and the submitted label only as manufacturer-public documentation.
A Suggested Cross-Check Workflow
A labeling research task can be structured as a three-source cross-check. First, identify the applicable requirement in 21 CFR Part 801, such as the name and place of business provision in 801.1 or the prominence requirements in 801.15 [3][7]. Second, retrieve any relevant guidance document to understand how FDA interprets that requirement for the device type [5]. Third, locate the manufacturer-submitted label in the FDA Online Label Repository or DailyMed, while recording that the label has not been verified by FDA [1].
This sequence prevents a common error: treating a submitted label as the regulatory standard. For example, a researcher checking whether a device label meets the name and place of business rule would read 21 CFR 801.1, which requires the label to specify conspicuously the name and place of business of the manufacturer, packer, or distributor [3]. The general device labeling page adds that the label must include street address, city, state, and zip code, with a limited exception when the street address appears in the local telephone directory [7]. The submitted label can then be compared against that requirement, but the comparison is the researcher's own analysis, not an FDA determination.
Sources & references
- FDA Label Search · labels.fda.gov
- Device Labeling | FDA · www.fda.gov
- eCFR :: 21 CFR Part 801 -- Labeling · www.ecfr.gov
- How to Study and Market Your Device | FDA · fda.gov
- Guidance Documents (Medical Devices and Radiation-Emitting Products) | FDA · www.fda.gov
- FDALabel: Full-Text Search of Drug Product Labeling | FDA · www.fda.gov
- General Device Labeling Requirements | FDA · www.fda.gov